coomassie brilliant blue has been researched along with Amyotrophic Lateral Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amadio, S; Apolloni, S; Armida, M; D'Ambrosi, N; Matteucci, A; Parisi, C; Popoli, P; Potenza, RL; Volonté, C | 1 |
| Ando, M; Fujita, K; Honda, M; Kato, T; Nagata, Y; Yamauchi, M | 1 |
2 other study(ies) available for coomassie brilliant blue and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Base Sequence; Biomarkers; DNA Primers; Female; Inflammation; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Microglia; Motor Neurons; Polymerase Chain Reaction; Purinergic P2X Receptor Antagonists; Rosaniline Dyes; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2014 |
Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis.
Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Electrophoresis, Polyacrylamide Gel; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Indicators and Reagents; Molecular Sequence Data; Molecular Weight; Rosaniline Dyes; Spinal Cord | 1998 |